[Radiofrequency treatment of hemangioma of nasal cavity under nasal endoscopy].

Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology · 2000 · Benefit · Very low evidence

← Research stream
BenefitVery low evidencePaper 3939

Fifteen nasal cavity hemangioma cases were treated with radiofrequency under nasal endoscopy; all lesions were reported as completely removed. No complications were reported and no recurrences were observed over 6 months to 4 years of follow-up; authors also …

Study snapshot

PublicationLin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology · 2000
Study typeother
Reported directionBenefit
Evidence ratingVery low

Abstract

OBJECTIVE: To further understand the advantage of radiofrequency treatment of hemangioma of nasal cavity under nasal endoscopy. METHOD: Fifteen cases with hemangioma of nasal cavity were treated with radiofrequency under nasal endoscopy. RESULT: The hemangioma of fifteen cases could be removed completely. The complication was absent. None of them recurred in six months to four years following up. CONCLUSION: This method has many advantages such as clear operation visual field, less hemorrhage and postoperative pain, no facial scar. The radiofrequency under endoscopy is valuable in treatment for hemangioma of nasal cavity.

Machine Enhanced Logic

AI evidence extraction

Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.

Study typeother
Effect directionbenefit
PopulationPatients with hemangioma of the nasal cavity
Sample size15
ExposureRF
Evidence strengthVery lowConfidence: 74% · Peer reviewed: yes

Main findings

Fifteen nasal cavity hemangioma cases were treated with radiofrequency under nasal endoscopy; all lesions were reported as completely removed. No complications were reported and no recurrences were observed over 6 months to 4 years of follow-up; authors also report less hemorrhage and postoperative pain and no facial scar.

Outcomes measured

  • Complete removal of hemangioma
  • Complications
  • Recurrence (6 months to 4 years follow-up)
  • Hemorrhage
  • Postoperative pain
  • Facial scarring

Limitations

  • No control/comparator group described
  • Small sample size (15 cases)
  • Radiofrequency exposure parameters (e.g., frequency, power, SAR) not reported
  • Follow-up duration varied (6 months to 4 years)
View raw extracted JSON
{
  "study_type": "other",
  "exposure": {
    "band": "RF",
    "source": "medical treatment (radiofrequency under nasal endoscopy)",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Patients with hemangioma of the nasal cavity",
  "sample_size": 15,
  "outcomes": [
    "Complete removal of hemangioma",
    "Complications",
    "Recurrence (6 months to 4 years follow-up)",
    "Hemorrhage",
    "Postoperative pain",
    "Facial scarring"
  ],
  "main_findings": "Fifteen nasal cavity hemangioma cases were treated with radiofrequency under nasal endoscopy; all lesions were reported as completely removed. No complications were reported and no recurrences were observed over 6 months to 4 years of follow-up; authors also report less hemorrhage and postoperative pain and no facial scar.",
  "effect_direction": "benefit",
  "limitations": [
    "No control/comparator group described",
    "Small sample size (15 cases)",
    "Radiofrequency exposure parameters (e.g., frequency, power, SAR) not reported",
    "Follow-up duration varied (6 months to 4 years)"
  ],
  "evidence_strength": "very_low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "radiofrequency",
    "nasal endoscopy",
    "hemangioma",
    "nasal cavity",
    "surgery",
    "recurrence",
    "complications"
  ],
  "suggested_hubs": []
}
AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.

Identifiers and source

DOI: Not supplied
PubMed: 12563717

Read the original paper →

Related papers

← Back to the Research Library